Adriana Matutino Kahn, Jing Du, Sarah Schellhorn, Michael DiGiovanna, Wajih Kidwai, Mariya Rozenblit, Daniel O'Neil, Robert Duffy Legare, Nicole Casasanta, Neal A. Fischbach, Kathleen Marie Fenn, Kim Blenman, Cristina Naranjo Ortiz, Wei Wei, Julia Maues, Ian E. Krop, Eric P. Winer, Maryam B. Lustberg, Lajos Pusztai. "Phase Ib randomized open-label trial of sacituzumab govitecan plus nivolumab or sacituzumab govitecan plus nivolumab and relatlimab as second-line therapy metastatic triple negative breast cancer: SIMONE trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1164